- Home
- OBK vs CDNA Comparison
OBK vs CDNA Comparison
Compare OBK & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBK
- CDNA
- Stock Information
- Founded
- OBK 1912
- CDNA 1998
- Country
- OBK United States
- CDNA United States
- Employees
- OBK N/A
- CDNA N/A
- Industry
- OBK Major Banks
- CDNA Medical Specialities
- Sector
- OBK Finance
- CDNA Health Care
- Exchange
- OBK Nasdaq
- CDNA Nasdaq
- Market Cap
- OBK 1.3B
- CDNA 1.1B
- IPO Year
- OBK 2018
- CDNA 2014
- Fundamental
- Price
- OBK $34.36
- CDNA $17.70
- Analyst Decision
- OBK Strong Buy
- CDNA Buy
- Analyst Count
- OBK 5
- CDNA 8
- Target Price
- OBK $44.00
- CDNA $29.43
- AVG Volume (30 Days)
- OBK 118.9K
- CDNA 639.4K
- Earning Date
- OBK 04-23-2025
- CDNA 05-08-2025
- Dividend Yield
- OBK 1.75%
- CDNA N/A
- EPS Growth
- OBK N/A
- CDNA N/A
- EPS
- OBK 2.45
- CDNA 0.93
- Revenue
- OBK $348,297,000.00
- CDNA $333,785,000.00
- Revenue This Year
- OBK $12.86
- CDNA $13.33
- Revenue Next Year
- OBK $7.15
- CDNA $15.07
- P/E Ratio
- OBK $14.01
- CDNA $19.09
- Revenue Growth
- OBK 2.10
- CDNA 19.07
- 52 Week Low
- OBK $27.69
- CDNA $7.42
- 52 Week High
- OBK $41.17
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- OBK 35.22
- CDNA 36.89
- Support Level
- OBK $34.65
- CDNA $18.16
- Resistance Level
- OBK $36.59
- CDNA $20.00
- Average True Range (ATR)
- OBK 0.80
- CDNA 0.83
- MACD
- OBK -0.05
- CDNA 0.00
- Stochastic Oscillator
- OBK 9.88
- CDNA 23.84
About OBK Origin Bancorp Inc.
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.